347 related articles for article (PubMed ID: 38612645)
1. The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies.
Chatzikalil E; Stergiou IE; Papadakos SP; Konstantinidis I; Theocharis S
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612645
[TBL] [Abstract][Full Text] [Related]
2. EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets.
Stergiou IE; Papadakos SP; Karyda A; Tsitsilonis OE; Dimopoulos MA; Theocharis S
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568780
[TBL] [Abstract][Full Text] [Related]
3. The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management.
Psilopatis I; Pergaris A; Vrettou K; Tsourouflis G; Theocharis S
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328669
[TBL] [Abstract][Full Text] [Related]
4. The role of Eph receptors and ephrin ligands in colorectal cancer.
Herath NI; Boyd AW
Int J Cancer; 2010 May; 126(9):2003-11. PubMed ID: 20039322
[TBL] [Abstract][Full Text] [Related]
5. May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
Psilopatis I; Karniadakis I; Danos KS; Vrettou K; Michaelidou K; Mavridis K; Agelaki S; Theocharis S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613532
[TBL] [Abstract][Full Text] [Related]
6. The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment.
Papadakos SP; Dedes N; Gkolemi N; Machairas N; Theocharis S
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769332
[TBL] [Abstract][Full Text] [Related]
7. Ephrin-Eph signaling usage by a variety of viruses.
de Boer ECW; van Gils JM; van Gils MJ
Pharmacol Res; 2020 Sep; 159():105038. PubMed ID: 32565311
[TBL] [Abstract][Full Text] [Related]
8. The role of ephrins and Eph receptors in cancer.
Surawska H; Ma PC; Salgia R
Cytokine Growth Factor Rev; 2004 Dec; 15(6):419-33. PubMed ID: 15561600
[TBL] [Abstract][Full Text] [Related]
9. Eph-ephrin bidirectional signaling in physiology and disease.
Pasquale EB
Cell; 2008 Apr; 133(1):38-52. PubMed ID: 18394988
[TBL] [Abstract][Full Text] [Related]
10. Eph/Ephrin Signaling in the Tumor Microenvironment.
Ieguchi K; Maru Y
Adv Exp Med Biol; 2021; 1270():45-56. PubMed ID: 33123992
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread.
Pergaris A; Danas E; Goutas D; Sykaras AG; Soranidis A; Theocharis S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445116
[TBL] [Abstract][Full Text] [Related]
12. Eph receptors and ephrins: therapeutic opportunities.
Barquilla A; Pasquale EB
Annu Rev Pharmacol Toxicol; 2015; 55():465-87. PubMed ID: 25292427
[TBL] [Abstract][Full Text] [Related]
13. Eph/ephrin signaling: networks.
Arvanitis D; Davy A
Genes Dev; 2008 Feb; 22(4):416-29. PubMed ID: 18281458
[TBL] [Abstract][Full Text] [Related]
14. Dying to communicate: apoptotic functions of Eph/Ephrin proteins.
Kandouz M
Apoptosis; 2018 Jun; 23(5-6):265-289. PubMed ID: 29767378
[TBL] [Abstract][Full Text] [Related]
15. Eph/ephrin signaling in cancer: intricate, puzzling and ... fascinating!
Alonso-Colmenar LM
Cell Adh Migr; 2012; 6(2):100-1. PubMed ID: 22814609
[TBL] [Abstract][Full Text] [Related]
16. Eph/ephrin signaling in epidermal differentiation and disease.
Lin S; Wang B; Getsios S
Semin Cell Dev Biol; 2012 Feb; 23(1):92-101. PubMed ID: 22040910
[TBL] [Abstract][Full Text] [Related]
17. EPH/Ephrin-Targeting Treatment in Breast Cancer: A New Chapter in Breast Cancer Therapy.
Psilopatis I; Souferi-Chronopoulou E; Vrettou K; Troungos C; Theocharis S
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499598
[TBL] [Abstract][Full Text] [Related]
18. Eph receptor and ephrin function in breast, gut, and skin epithelia.
Perez White BE; Getsios S
Cell Adh Migr; 2014; 8(4):327-38. PubMed ID: 25482622
[TBL] [Abstract][Full Text] [Related]
19. Bidirectional ephrin/Eph signaling in synaptic functions.
Aoto J; Chen L
Brain Res; 2007 Dec; 1184():72-80. PubMed ID: 17166489
[TBL] [Abstract][Full Text] [Related]
20. The EPH/Ephrin System in Bone and Soft Tissue Sarcomas' Pathogenesis and Therapy: New Advancements and a Literature Review.
Hadjimichael AC; Pergaris A; Kaspiris A; Foukas AF; Kokkali S; Tsourouflis G; Theocharis S
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
